Gene therapies are still hampered by substantial delays between their date of approval and the time they launch. And it isn’t simply a matter of not having a payment or reimbursement system in place. Manufacturing and patient preparation delays figure prominently.
Subscribe to:
Post Comments (Atom)
< + > How Healthcare Analytics Dashboards Lose Operational Clarity: The Hidden Cost of Metric Inflation
The following is a guest article by Tanya Amar, Senior BI & Insights Analyst at eHealth Picture this: you’re a data analyst leading a d...
No comments:
Post a Comment